KTTA 0.80 ▼ -6.31% Live Trading Data - Stocknear

Pasithea Therapeutics Cor...

NASDAQ: KTTA · Real-Time Price · USD
0.80
-0.05 (-6.31%)
At close: Sep 04, 2025, 3:59 PM
0.80
0.50%
After-hours: Sep 04, 2025, 06:33 PM EDT
-6.31%
Bid 0.74
Market Cap 5.93M
Revenue (ttm) 649.03K
Net Income (ttm) -13.46M
EPS (ttm) -7.13
PE Ratio (ttm) -0.11
Forward PE n/a
Analyst n/a
Ask 0.8
Volume 155,915
Avg. Volume (20D) 150,022
Open 0.77
Previous Close 0.85
Day's Range 0.77 - 0.83
52-Week Range 0.65 - 7.50
Beta 0.26

About KTTA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KTTA
Website n/a
Full Company Profile
3 months ago
+11.09%
Pasithea Therapeutics shares are trading higher af... Unlock content with Pro Subscription
3 months ago
+11.07%
Pasithea Therapeutics shares are trading higher after the company announced initiation of its Phase 1/1b open label study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of PAS-004, in adult participants with neurofibromatosis type 1 with symptomatic and inoperable, incompletely resected, or recurrent plexiform neurofibromas.